These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

418 related items for PubMed ID: 30457358

  • 1. Cost effectiveness of implementing ESC guidelines for treatment of iron deficiency in heart failure in the Nordic countries.
    Hofmarcher T, Cabrales Alin D, Linde C.
    Scand Cardiovasc J; 2018 Dec; 52(6):348-355. PubMed ID: 30457358
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Ferric carboxymaltose in patients with heart failure and iron deficiency.
    Anker SD, Comin Colet J, Filippatos G, Willenheimer R, Dickstein K, Drexler H, Lüscher TF, Bart B, Banasiak W, Niegowska J, Kirwan BA, Mori C, von Eisenhart Rothe B, Pocock SJ, Poole-Wilson PA, Ponikowski P, FAIR-HF Trial Investigators.
    N Engl J Med; 2009 Dec 17; 361(25):2436-48. PubMed ID: 19920054
    [Abstract] [Full Text] [Related]

  • 6. Economic Evaluation of Ferric Carboxymaltose for the Management of Hemodialysis Patients with Iron Deficiency Anemia in Italy.
    Rognoni C, Ortalda V, Biasi C, Gambaro G.
    Adv Ther; 2019 Nov 17; 36(11):3253-3264. PubMed ID: 31489572
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Budget impact of intravenous ferric carboxymaltose in patients with chronic heart failure and iron deficiency in France.
    Bourguignon S, Faller M, Champs FO, Moutier H, Levesque K, Caranhac G, Cohen-Solal A.
    ESC Heart Fail; 2019 Jun 17; 6(3):559-569. PubMed ID: 31021531
    [Abstract] [Full Text] [Related]

  • 9. Determinants of quality of life of patients with heart failure and iron deficiency treated with ferric carboxymaltose: FAIR-HF sub-analysis.
    Gutzwiller FS, Pfeil AM, Comin-Colet J, Ponikowski P, Filippatos G, Mori C, Braunhofer PG, Szucs TD, Schwenkglenks M, Anker SD.
    Int J Cardiol; 2013 Oct 09; 168(4):3878-83. PubMed ID: 23870642
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial.
    Ponikowski P, Kirwan BA, Anker SD, McDonagh T, Dorobantu M, Drozdz J, Fabien V, Filippatos G, Göhring UM, Keren A, Khintibidze I, Kragten H, Martinez FA, Metra M, Milicic D, Nicolau JC, Ohlsson M, Parkhomenko A, Pascual-Figal DA, Ruschitzka F, Sim D, Skouri H, van der Meer P, Lewis BS, Comin-Colet J, von Haehling S, Cohen-Solal A, Danchin N, Doehner W, Dargie HJ, Motro M, Butler J, Friede T, Jensen KH, Pocock S, Jankowska EA, AFFIRM-AHF investigators.
    Lancet; 2020 Dec 12; 396(10266):1895-1904. PubMed ID: 33197395
    [Abstract] [Full Text] [Related]

  • 13. Heart failure in patients with kidney disease and iron deficiency; the role of iron therapy.
    Cases Amenós A, Ojeda López R, Portolés Pérez JM, en representación del Grupo de Anemia de la S.E.N..
    Nefrologia; 2017 Dec 12; 37(6):587-591. PubMed ID: 28610806
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Anaemia and iron deficiency in clinical practice:from cardiology to gastroenterology and beyond].
    Češka R.
    Vnitr Lek; 2014 Dec 12; 60(12):1033-9. PubMed ID: 25692829
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Ferric carboxymaltose: a review of its use in iron deficiency.
    Keating GM.
    Drugs; 2015 Jan 12; 75(1):101-27. PubMed ID: 25428711
    [Abstract] [Full Text] [Related]

  • 19. Financial impact of intravenous iron treatments on the management of anaemia inpatients: a 1 year observational study.
    Delpeuch A, Ruivard M, Abergel A, Aumaitre O, Boisgard S, Bagel S, Sautou V.
    Int J Clin Pharm; 2018 Jun 12; 40(3):686-692. PubMed ID: 29520555
    [Abstract] [Full Text] [Related]

  • 20. Cost-utility analysis of ferric derisomaltose versus ferric carboxymaltose in patients with inflammatory bowel disease and iron deficiency anemia in England.
    Iqbal TH, Kennedy N, Dhar A, Ahmed W, Pollock RF.
    J Med Econ; 2024 Jun 12; 27(1):392-403. PubMed ID: 38391240
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.